The Beatson Institute for Cancer Research

Last updated

The Beatson Institute for Cancer Research Building, Glasgow, Scotland, May 2008 BICR building- 2008.jpg
The Beatson Institute for Cancer Research Building, Glasgow, Scotland, May 2008

The Beatson Institute for Cancer Research (also known as the Cancer Research UK Scotland Institute, [1] formerly known as the Cancer Research UK Beatson Institute) is a biological research facility that conducts research into the basic biology of cancer. It is based in Glasgow, Scotland.

Contents

The Institute is named in recognition of Sir George Beatson, a surgeon, who in 1912 established a research department in the cancer hospital in Glasgow. [2] This department became independent from the hospital in 1967 when the Institute was founded by the then Director, Dr John Paul. Dr Paul raised sufficient funds to move the Beatson in 1976 to its present location on the Garscube Estate, where it has since interacted closely with researchers at the University of Glasgow. The Institute moved in 2008 to a new research building built by Reiach and Hall Architects. [3]

Professor John Wyke became Director in 1987, Professor Karen Vousden in 2002 and Professor Owen Sansom in 2017. [4]

Research groups at the Beatson Institute study cancer initiation, metabolism and metastasis. The Institute holds an annual meeting, the Beatson International Cancer Conference, focused on one of these topics. [5]

Notable present and former scientists and physicians

See also

Related Research Articles

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

Morag Crichton Timbury FRCPG FRCPath FRSE FRCP was a Scottish medical virologist, bacteriologist and science writer.

<span class="mw-page-title-main">Allan Glen's School</span> Secondary school in Scotland

Allan Glen's School was, for most of its existence, a local authority, selective secondary school for boys in Glasgow, Scotland, charging nominal fees for tuition.

<span class="mw-page-title-main">Beatson West of Scotland Cancer Centre</span> Specialised cancer care centre in Glasgow, Scotland

The Beatson West of Scotland Cancer Centre is a specialised cancer care centre in Glasgow, Scotland. Until recently it had facilities in Gartnavel General Hospital, the Western Infirmary and Glasgow Royal Infirmary. As part of the NHS Greater Glasgow and Clyde Acute Services Review, the centre is being centralised within new facilities at the Gartnavel General Hospital site.

Karen Heather Vousden, CBE, FRS, FRSE, FMedSci is a British medical researcher. She is known for her work on the tumour suppressor protein, p53, and in particular her discovery of the important regulatory role of Mdm2, an attractive target for anti-cancer agents. From 2003 to 2016, she was the director of the Cancer Research UK Beatson Institute in Glasgow, UK, moving back to London in 2016 to take up the role of Chief Scientist at CRUK and Group Leader at the Francis Crick Institute.

<span class="mw-page-title-main">Gordon McVie</span> British oncologist and cancer researcher (1945–2021)

John Gordon McVie was an international authority on the treatment and research of cancer. He wrote over 350 peer-reviewed articles, editorials and books. McVie was born in Glasgow, Scotland and died of non-Hodgkin lymphona and COVID-19 in Bristol, England.

Christopher John Marshall FRS FMedSci was a British scientist who worked as director of the Division for Cancer Biology at the Institute of Cancer Research. Marshall was distinguished for research in the field of tumour cell signalling. His track record includes the discovery of the N-Ras oncogene , the identification of farnesylation of Ras proteins, and the discovery that Ras signals through the MAPK/ERK pathway. These findings have led to therapeutic development of inhibitors of Ras farnesylation, MEK and B-Raf.

Dame Anna Felicja Dominiczak DBE FRCP FRSE FAHA FMedSci is a Polish-born British medical researcher, Regius Professor of Medicine - the first woman to hold this position, and the Chief Scientist (Health) for the Scottish Government. From 2010 to 2020, Dominiczak was the Vice-Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow, Scotland. She is an Honourary Consultant Physician and Endocrinologist for the NHS Greater Glasgow and Clyde Health Board, and Health Innovation Champion for the Medical Research Council. From 2013 to 2015, Dominiczak was president of the European Society of Hypertension. She is the current Editor-in-Chief of Precision Medicine, a new journal launched in July 2023.

<span class="mw-page-title-main">George Beatson</span> British physician

Colonel Sir George Thomas Beatson was a British physician. He was a pioneer in the field of oncology, developing a new treatment for breast cancer, and has been called "the father of endocrine ablation in cancer management." The Beatson West of Scotland Cancer Centre and the Cancer Research UK Beatson Institute are named for him.

<span class="mw-page-title-main">Ian Ford</span> Scottish doctor, academic

Ian Ford [ FRSE FRCP(Glas) FSCT ] is a professor of biostatistics and a director of the Robertson Centre for Biostatistics, and a former Dean of Faculty of Information and Mathematical Sciences, at the University of Glasgow.

<span class="mw-page-title-main">Tessa Holyoake</span> Scottish oncology physician and leukemia researcher

Tessa Laurie Holyoake, was a Scottish haematology-oncology physician. She specialised in chronic myeloid leukaemia (CML), and discovered its stem cell. She was considered a world leading expert in leukaemia research.

Prof David Richmond Newth FRSE PhD (1921-1988) was a British zoologist and scientific author.

<span class="mw-page-title-main">Sheila Rowan (physicist)</span> Professor of Physics, Chief Scientific Advisor to the Scottish Government

Sheila Rowan is a Scottish physicist and academic, who is Professor of Physics and Astronomy at the University of Glasgow in Scotland, and director of its Institute for Gravitational Research since 2009. She is known for her work in advancing the detection of gravitation waves. In 2016, Rowan was appointed the (part-time) Chief Scientific Advisor to the Scottish Government.

<span class="mw-page-title-main">Caroline Dive</span> Professor of Cancer Pharmacology

Caroline Dive is a British cancer research scientist. Dive is Professor of Cancer Pharmacology at the University of Manchester, Deputy Director of the Cancer Research UK (CRUK) Manchester Institute, Director of the CRUK Manchester Institute Cancer Biomarker Centre and co-director of the CRUK Lung Cancer Centre of Excellence. She is the current President of The European Association for Cancer Research (EACR).

<span class="mw-page-title-main">Charles Swanton</span>

(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.

Owen Sansom, FRSE., FMedSci is the Director of the Cancer Research UK Beatson Institute. He is known for his work determining the molecular hallmarks of colorectal cancer (CRC), including demonstrating the roles of the tumour suppressor protein APC and the WNT signalling pathway, as well as the involvement of intestinal stem cells in tumourigenesis

The University of Glasgow's Glasgow Precision Oncology Laboratory (GPOL) is a molecular research facility that partners with the NHS and industry to perform research into the development of novel therapeutic strategies, the creation of pan-cancer genomic assays and provide knowledge transfer for healthcare systems to enable them to develop landscapes for therapeutic testing in cancer.

Norna Robertson is a lead scientist at LIGO at California Institute of Technology, and professor of experimental physics at the University of Glasgow. Her career has focused on experimental research into suspension systems and instrumentation to achieve the detection of gravitational waves.

Laura Machesky FRSE FMedSci is a British-American cancer research scientist currently based in the University of Cambridge. Professor Machesky is the Sir William Dunn Professor of Biochemistry in the Department of Biochemistry, and the current president of the British Society for Cell Biology.

Robert Insall is a Professor of Mathematical and Computational Cell Biology at the University of Glasgow and a Senior Group Leader at the Beatson Institute for Cancer Research. His work focuses on how eukaryotic cells move, and how they choose the direction in which they move. He is known for demonstrating that cells can spread in the body and find their way through mazes by creating gradients of chemoattractants.

References

  1. https://news.cancerresearchuk.org/2023/09/20/cruks-largest-ever-investment-in-scotland-bolsters-institute-science/
  2. https://www.beatson.scot.nhs.uk/about-us/history-of-the-beatson/
  3. "Reiach and Hall Architects". reiachandhall.co.uk. Retrieved 27 September 2016.
  4. "Q&A: Owen Sansom on stepping up as Director of our CRUK Beatson Institute". Cancer Research UK.
  5. https://www.beatson.gla.ac.uk/about.html ×